Inactive Instrument
Legion Metals Corp Stock Canadian Securities Exchange
Stocks
CA52490L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.8M 4.91M 4.21M 3.94M 3.6M 468M 6.86M 46.51M 18.11M 236M 18.44M 18.04M 782M | P/E 2024 |
-8x | P/E 2025 | -71.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.81M 4.92M 4.21M 3.95M 3.61M 469M 6.87M 46.57M 18.13M 236M 18.46M 18.06M 783M | EV / Sales 2024 |
1.05x | EV / Sales 2025 | 1.05x |
| Free-Float |
98.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -71.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 2023-09-07 |
Ted Kim
DFI | Director of Finance/CFO | - | - |
Sam Kassem
DFI | Director of Finance/CFO | - | 2023-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Andrews
BRD | Director/Board Member | - | 2023-09-26 |
Sherry Boodram
BRD | Director/Board Member | - | 2019-10-15 |
Fred Bonner
BRD | Director/Board Member | 64 | 2024-02-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -71.43% | -.--% | - | - | 4.91M | ||
| +0.89% | +6.02% | +8.47% | +14.51% | 2.57B | ||
| +1.62% | +16.82% | +32.40% | +217.98% | 2.15B | ||
| -1.79% | -3.02% | -50.20% | +240.00% | 532M | ||
| 0.00% | +1.79% | -3.39% | +42.50% | 62.96M | ||
| Average | -14.14% | +5.59% | -3.18% | +128.75% | 1.33B | |
| Weighted average by Cap. | +0.84% | +8.79% | +12.12% | +119.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.48M 9.01M 7.72M 7.24M 6.61M 859M 12.6M 85.38M 33.24M 434M 33.85M 33.11M 1.44B | 11.26M 8.14M 6.97M 6.53M 5.97M 776M 11.38M 77.08M 30.01M 391M 30.56M 29.89M 1.3B |
| Net income | -1.44M -1.04M -889K -833K -761K -98.91M -1.45M -9.83M -3.83M -49.9M -3.9M -3.81M -165M | -163K -118K -101K -94.52K -86.34K -11.22M -165K -1.11M -434K -5.66M -442K -432K -18.75M |
| Net Debt | -53.84K -38.9K -33.33K -31.23K -28.53K -3.71M -54.37K -368K -143K -1.87M -146K -143K -6.2M | 7.72K 5.58K 4.78K 4.48K 4.09K 532K 7.8K 52.85K 20.57K 268K 20.95K 20.5K 889K |
Employees
-
Sector
Pharmaceuticals
















